Effect of Sweetness Intensity of a Sucrose Solution on Blood Glucose Regulation and Energy Intake
NCT ID: NCT04991714
Last Updated: 2023-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
30 participants
INTERVENTIONAL
2021-08-05
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessments of Metabolic Responses to Acute Oral Administration of Sucrose, Glucose, and Fructose
NCT06799715
Effect of Artificial Sweetener (AFS) on Glucose Metabolism in Patients with Type 1 Diabetes (T1D)
NCT06315725
The Effect of Artificial Sweeteners on Blood Glucose Response
NCT01246492
The Effect of Lactisole on the Responses to Glucose Solution
NCT01121783
The Effect of Ingesting or Rinsing Sucrose and Sucralose on Self-control, Cognitive Performance, and Blood Glucose
NCT02075333
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sucrose
10% solution in water
Sucrose
10% Sucrose corresponding to a regular soft drink
Sucrose + Reb M
10% sucrose + 60 mg/L Rebaudioside M
Rebaudioside M
Sweetener (increases sweetness)
Sucrose
10% Sucrose corresponding to a regular soft drink
Sucrose + Lactisole
10% sucrose + 30 mg/ L Lactisole
Lactisole
sweet taste inhibitor (decreases sweetness)
Sucrose
10% Sucrose corresponding to a regular soft drink
Sucrose + Reb M + Lactisole
10% sucrose + 60 mg/L Rebaudioside M + 30 mg/ L Lactisole
Lactisole
sweet taste inhibitor (decreases sweetness)
Rebaudioside M
Sweetener (increases sweetness)
Sucrose
10% Sucrose corresponding to a regular soft drink
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactisole
sweet taste inhibitor (decreases sweetness)
Rebaudioside M
Sweetener (increases sweetness)
Sucrose
10% Sucrose corresponding to a regular soft drink
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy
* non-smoking
* normal taste responses towards sweet taste
Exclusion Criteria
* regular smokers
* disturbed glucose and/or lipid metabolism
* regular intake of medication
* known allergies against one of the test compounds
* ageusia
* alcohol or drug addiction
* intake of antibiotics within the past 2 months
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barbara Lieder
Deptuy Head Department of Physiological Chemistry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barbara Lieder, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Christian Doppler Laboratory for Taste Research
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
706014-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.